Tue, Jul 22, 2014, 10:57 AM EDT - U.S. Markets close in 5 hrs 3 mins


% | $
Click the to save as a favorite.

Sarepta Therapeutics, Inc. Message Board

  • zwerp2000 zwerp2000 Apr 16, 2013 8:54 AM Flag

    Baird out with a note

    Sarepta FDA delay should be viewed as positive, says RW Baird

    Baird believes the FDA's request for additional information from Sarepta comes across as a delay but the language in the minutes increases their confidence in a path to accelerated approval. The firm believes the request signals an openness on the FDA's part and an additional Phase 3 study does not appear to be needed. Baird expects a management update on a decision in Q3. Shares remain Outperform rated with a $63 price target

22.05+0.48(+2.23%)10:57 AMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.